Obsessive-Compulsive DisorderOCDNCT04215549
The Cost of Obsessive-compulsive Disorder (OCD) in China
An observational study of Obsessive-Compulsive Disorder, run by Shanghai Mental Health Center at 1 site in China.
Trial summary
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective. Read more about this study
- Who is it for?
- Ages 16 to 65 years
- Conditions the study is for
- Obsessive-Compulsive Disorder
- How many people
- 0 participants
- Where
- 1 siteChina
- Study dates
- 2 Jan 2020to Oct 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 65 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: patients with obsessive-compulsive disorder are recruited from both outpatient clinics and inpatient departments
Who may be able to join
- primarily diagnosed OCD meet DSM-5 critera
- 16-65 years old
- Get informed consent from patients
Who cannot join
- Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs
- Drug abuser
- Unable to understand the questionnaire
Trial locations and contacts
1 site in 1 country.
China1 site
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030
About this study
Official title: The Cost of Obsessive-compulsive Disorder (OCD) in China: Multi-center Cross-sectional Survey Based on Hospital
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.
Read the detailed description
Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.
- Conditions
- Obsessive-Compulsive Disorder
- Being tested
- No intervention
- Medical subject headings
- Obsessive-Compulsive Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
cross sectional study，no intervention
| Study group | Role | What they receive |
|---|---|---|
| Participants | OCD patients come from 13 hospitals located in the north, south, east and west of China Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
obsessive-compulsive disorder related costs in China
Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective
Measured: 1 year
Secondary outcomes (2)
Direct costs and indirect costs of consumed resources
Direct costs include medical costs and transportation, food, accommodation, etc. corresponding related to clinics.Indirect costs include lost time for patients and family members due to OCD.
Measured: 1 year
other costs directly associated with OCD
Other medical costs and economic loss of disruptive behaviors due to OCD
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jan 2020
- Study start2 Jan 2020
- Primary completionOct 2020 (estimated)
- Study completionOct 2020 (estimated)
Why it stopped: Because of COVID-19, we cann't carry out recruiting according to the original plan
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obsessive-Compulsive DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Shanghai Mental Health Center
- Sponsor type
- University, hospital or other
- Collaborators
- Capital Medical University, Peking University Sixth Hospital, First Affiliated Hospital Xi'an Jiaotong University, Shandong Provincial Hospital, Qingdao No. 7 People's Hospital, the First Psychiatric Hospital of Harbin, Qiqihar Medical University, The Second Affiliated Hospital of Xinxiang Medical College, Seventh People's Hospital of Hangzhou, Guangji Hospital Affiliated to Soochow University, First Affiliated Hospital of Kunming Medical University, Guangzhou Mental Hospital
- Responsible party
- Principal investigator, Zhen Wang, Shanghai Mental Health Center
- Investigators
- Wang Zhen, PhD,MD, Principal investigator, Shanghai Mental Health Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04215549
- Sponsor's protocol ID
- SMHC-OCD-5
- Acronym
- OCD
- Status last verified
- Nov 2020
- First submitted
- 30 Dec 2019
- Last updated
- 17 Nov 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Cost of Obsessive-compulsive Disorder (OCD) in China: Multi-center Cross-sectional Survey Based on Hospital
- ClinicalTrials.gov ID
- NCT04215549
- Acronym / sponsor ID
- OCD / SMHC-OCD-5
- Conditions
- Obsessive-Compulsive Disorder
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Because of COVID-19, we cann't carry out recruiting according to the original plan
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Shanghai Mental Health CenterUniversity, hospital or other
- Collaborators
- Capital Medical University, Peking University Sixth Hospital, First Affiliated Hospital Xi'an Jiaotong University, Shandong Provincial Hospital, Qingdao No. 7 People's Hospital, the First Psychiatric Hospital of Harbin, Qiqihar Medical University, The Second Affiliated Hospital of Xinxiang Medical College, Seventh People's Hospital of Hangzhou, Guangji Hospital Affiliated to Soochow University, First Affiliated Hospital of Kunming Medical University, Guangzhou Mental Hospital
- Study start
- 2 Jan 2020 (actual)
- Primary completion
- Oct 2020 (estimated)
- Study completion
- Oct 2020 (estimated)
- First posted
- 2 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.
Detailed description
Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Participants | – | Other: No interventionOCD patients come from 13 hospitals located in the north, south, east and west of China |
Who may qualify
- Ages
- 16 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patients with obsessive-compulsive disorder are recruited from both outpatient clinics and inpatient departments
Key inclusion criteria (3 listed)
- primarily diagnosed OCD meet DSM-5 critera
- 16-65 years old
- Get informed consent from patients
Key exclusion criteria (3 listed)
- Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs
- Drug abuser
- Unable to understand the questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventioncross sectional study，no intervention | Other | Participants |
Primary outcome
obsessive-compulsive disorder related costs in China
Time frame: 1 year
Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective
2 secondary outcomes
Direct costs and indirect costs of consumed resources
Time frame: 1 year
other costs directly associated with OCD
Time frame: 1 year
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Nov 2020.
Related trials for Obsessive-Compulsive Disorder
Enrolling by invitation
Family Accommodation Reduction in Adult Obsessive Compulsive Disorder
Obsessive - Compulsive Disorder, Family Accommodation
Not yet recruitingObservational study
Investigation of Obsessive-Compulsive Disorder in Patients With Elbow Epicondylitis
Lateral Epicondylitis, Medial Epicondylitis
Recruiting
Precision Analytic Research Methods in OCD
Obsessive Compulsive Disorder
Recruiting
Focused Ultrasound for Behavioral Health
Depression, Anxiety
Not yet recruiting
Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Treatment-refractory Obsessive-compulsive Disorder (trOCD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Wang Zhen, PhD,MD principal investigator
Shanghai Mental Health Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Obsessive-Compulsive Disorder, run by Shanghai Mental Health Center at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 17 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
obsessive-compulsive disorder related costs in China (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2020.